News

For The First Time, A Potential Treatment Option For All Uveal Melanoma Patients

Jul 13, 2026 in Melanoma

From Chemotherapy to Targeted Pills: A New Era in Chronic Myeloid Leukemia and What Asciminib Could Mean for Patients

Jun 30, 2026

FDA Approves Ibrance Combination as New Maintenance Option for HR+/HER2+ Metastatic Breast Cancer

Jun 29, 2026 in Breast Cancer

New FDA Approval May Help Reduce the Risk of Kidney Cancer Returning After Surgery-- What Patients Need To Know About Welireg

Jun 29, 2026

Better Options for Treating Anemia in Lower-Risk Myelodysplastic Syndrome

Jun 26, 2026

Daejin Abidoye On AbbVie's Mission: "Finding the Right Patient for the Right Drug at the Right Time"

Jun 26, 2026

New Clinical Trial Data Bring Hope for Metastatic Triple-Negative Breast Cancer

Jun 25, 2026 in Breast Cancer

How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care

Jun 25, 2026

How Drugmaker Eisai Is Working to Expand Treatment Options for People With Cancer: A Conversation With Oncology Leader Dr. Corina Dutcus

Jun 25, 2026

Taking Kisqali Earlier Helps Prevent Recurrence For Patients With HR+ Breast Cancer Regardless of Subtype

Jun 24, 2026 in Breast Cancer

'A Watershed Moment': Revolution Medicines Chief Development Officer Dr. Alan Sandler On The Breakthrough Giving New Hope in Pancreatic Cancer

Jun 24, 2026

FDA Approves First-of-its-Kind Drug For Advanced Prostate Cancer With Common PTEN Deficiency Mutation

Jun 19, 2026 in Prostate Cancer